BACKGROUND: Stereotactic body radiotherapy (SBRT) has emerged recently as a novel therapeutic alternative for patients with ventricular tachycardias (VTs) resistant to convetional treatment. Nevertheless, many aspects related to SBRT are currently unknown. CASE SUMMARY: A 66-year-old man with ischaemic heart disease, a history of coronary artery bypass graft surgery and left ventricular dysfunction was referred for recurrent symptomatic episodes of slow VT (108 b.p.m.). The arrhythmia was resistant to antiarrhythmic drug therapy with amiodarone and repeated catheter ablation. The patient was scheduled to SBRT, however, the first session failed to suppress VT recurrences. After 20 months, the patient underwent re-do ablation procedure that revealed a newly developed scar with its core adjacent to the presumed critical part of the VT substrate. Catheter ablation again failed to eliminate VT and the second session of SBRT was scheduled. To improve targeting of the VT substrate for SBRT, we applied our recently developed original method for integration of data from the electroanatomical mapping system with computer tomography images. The second session of SBRT with precise targeting using the novel strategy led within 3 months to the successful elimination of VT. DISCUSSION: This case report describes a patient in whom the recurrent VT was abolished only by properly targeted SBRT. Above all, the case highlights the importance of precise identification and targeting for SBRT. Our case also documents in vivo, by electroanatomical voltage mapping, the development of SBRT-related myocardial lesion. This represents an important mechanistic proof of the concept of SBRT.

Department of Cardiology Institute for Clinical and Experimental Medicine Vídeňská 1958 9 Prague 140 21 Czech Republic

Department of Oncology University Hospital Ostrava 17 listopadu 1790 5 Ostrava 708 00 Czech Republic

Zobrazit více v PubMed

Cronin EM, Bogun FM, Maury P, Peichl P, Chen M, Namboodiri N. et al.; ESC Scientific Document Group. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Europace 2019;21:1143–1144. PubMed PMC

Neuwirth R, Cvek J, Knybel L, Jiravsky O, Molenda L, Kodaj M. et al. Stereotactic radiosurgery for ablation of ventricular tachycardia. Europace 2019;21:1088–1095. PubMed

Cuculich PS, Schill MR, Kashani R, Mutic S, Lang A, Cooper D. et al. Noninvasive cardiac radiation for ablation of ventricular tachycardia. N Engl J Med 2017;377:2325–2336. PubMed PMC

Robinson CG, Samson PP, Moore KMS, Hugo GD, Knutson N, Mutic S. et al. Phase I/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia. Circulation 2019;139:313–321. PubMed PMC

Haskova J, Peichl P, Pirk J, Cvek J, Neuwirth R, Kautzner J.. Stereotactic radiosurgery as a treatment for recurrent ventricular tachycardia associated with cardiac fibroma. HeartRhythm Case Rep 2019;5:44–47. PubMed PMC

Sramko M, Cvek J, Peichl P, Knybel L, Kautzner J.. Stereotactic radioablation of ventricular tachycardia guided by direct integration of 3D electroanatomic mapping: development and validation of a new method. Eur Heart J 2019;40 (Supplement_1):3122.

Hutchinson MD, Gerstenfeld EP, Desjardins B, Bala R, Riley MP, Garcia FC. et al. Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 2011;4:49–55. PubMed PMC

Bear LR, LeGrice IJ, Sands GB, Lever NA, Loiselle DS, Paterson DJ. et al. How accurate is inverse electrocardiographic mapping? A systematic in vivo evaluation. Circ Arrhythm Electrophysiol 2018;11:e006108. PubMed

Bhaskaran A, Tung R, Stevenson WG, Kumar S.. Catheter ablation of VT in non-ischaemic cardiomyopathies: endocardial, epicardial and intramural approaches. Hear Lung Circ 2019;28:84–101. PubMed

Desai MY, Windecker S, Lancellotti P, Bax JJ, Griffin BP, Cahlon O. et al. Prevention, diagnosis, and management of radiation-associated cardiac disease: JACC Scientific Expert Panel. J Am Coll Cardiol 2019;74:905–927. PubMed

Wang K, Eblan MJ, Deal AM, Lipner M, Zagar TM, Wang Y. et al. Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy. J Clin Oncol 2017;35:1387–1394. PubMed PMC

Song CW, Glatstein E, Marks LB, Emami B, Grimm J, Sperduto PW. et al. Biological principles of stereotactic body radiation therapy (SBRT) and stereotactic radiation surgery (SRS): indirect cell death. Int J Radiat Oncol Biol Phys 2019;doi: 10.1016/j.ijrobp.2019.02.047. PubMed

Scholz EP, Seidensaal K, Naumann P, André F, Katus HA, Debus J.. Risen from the dead: cardiac stereotactic ablative radiotherapy as last rescue in a patient with refractory ventricular fibrillation storm. HeartRhythm Case Rep 2019;5:329–332. PubMed PMC

Jumeau R, Ozsahin M, Schwitter J, Vallet V, Duclos F, Zeverino M. et al. Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation. Radiother Oncol 2018;128:189–191. PubMed

Sharma A, Wong D, Weidlich G, Fogarty T, Jack A, Sumanaweera T. et al. Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atrium. Heart Rhythm 2010;7:802–810. PubMed

Optimized target delineation procedure for the radiosurgery treatment of ventricular tachycardia: observer-independent accuracy

Inflammation and fibrosis characterize different stages of myocardial remodeling in patients after stereotactic body radiotherapy of ventricular myocardium for recurrent ventricular tachycardia

Repeated stereotactic radiotherapy of recurrent ventricular tachycardia

Retrograde coronary venous ethanol ablation of ventricular tachycardia in a patient after aortic valve replacement and failed both radiofrequency ablation and stereotactic radiotherapy

Case Report: Repeated Stereotactic Radiotherapy of Recurrent Ventricular Tachycardia: Reasons, Feasibility, and Safety